RT Journal Article
SR Electronic
T1 Interleukin-17A Mediates Resistance to Anti-VEGF Therapy
JF Cancer Discovery
JO CANCER DISCOVERY
FD American Association for Cancer Research
SP OF16
OP OF16
DO 10.1158/2159-8290.CD-RW2013-176
VO 3
IS 10
YR 2013
UL http://cancerdiscovery.aacrjournals.org/content/3/10/OF16.abstract
AB Interleukin (IL)-17-secreting TH17 cells reduce sensitivity to VEGF-specific antibodies.